947249-08-3 Usage
Uses
Used in Pharmaceutical Industry:
Acetamide, N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-2-yl]is used as a pharmaceutical compound for its potential therapeutic applications. The presence of the imidazopyridine group may offer biological activity, making it a candidate for the development of new drugs. Its boron-containing functionalities could also be exploited for targeted drug delivery or as a component in the synthesis of complex pharmaceutical molecules.
Used in Materials Science:
In the field of materials science, Acetamide, N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-2-yl]may be utilized for the development of advanced materials with unique properties. The combination of functional groups could contribute to the creation of new materials with enhanced performance characteristics, such as improved stability, reactivity, or selectivity.
Used in Organic Synthesis:
Acetamide, N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridin-2-yl]is used as a synthetic intermediate or reagent in organic synthesis. Its diverse functional groups can be employed in various chemical reactions, facilitating the synthesis of complex organic molecules. The 1,3,2-dioxaborolan-2-yl group may also be used as a protecting group or in cross-coupling reactions, enabling the formation of new chemical bonds and the construction of intricate molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 947249-08-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,7,2,4 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 947249-08:
(8*9)+(7*4)+(6*7)+(5*2)+(4*4)+(3*9)+(2*0)+(1*8)=203
203 % 10 = 3
So 947249-08-3 is a valid CAS Registry Number.
947249-08-3Relevant academic research and scientific papers
HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND APPLICATION THEREOF
-
Paragraph 00128-00129, (2018/02/20)
The present disclosure provides heteroaryl compounds of formulas (I), (Ia) and (Ib), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosi
Inhibitors of PI3 kinase
-
Page/Page column 26; 27, (2009/07/10)
The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.
